Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/8787
Title: Gamma Ventral Capsulotomy for Obsessive-Compulsive Disorder A Randomized Clinical Trial
Authors: LOPES, Antonio C.GREENBERG, Benjamin D.CANTERAS, Miguel M.BATISTUZZO, Marcelo C.HOEXTER, Marcelo Q.GENTIL, Andre F.PEREIRA, Carlos A. B.JOAQUIM, Marines A.MATHIS, Maria E. deD'ALCANTE, Carina C.TAUB, AnitaCASTRO, Douglas G. deTOKESHI, LucasSAMPAIO, Leonardo A. N. P. C.LEITE, Claudia C.SHAVITT, Roseli G.DINIZ, Juliana B.BUSATTO, GeraldoNOREN, GeorgRASMUSSEN, Steven A.MIGUEL, Euripedes C.
Citation: JAMA PSYCHIATRY, v.71, n.9, p.1066-1076, 2014
Abstract: IMPORTANCE Select cases of intractable obsessive-compulsive disorder (OCD) have undergone neurosurgical ablation for more than half a century. However, to our knowledge, there have been no randomized clinical trials of such procedures for the treatment of any psychiatric disorder. OBJECTIVE To determine the efficacy and safety of a radiosurgery (gamma ventral capsulotomy [GVC]) for intractable OCD. DESIGN, SETTING, AND PARTICIPANTS In a double-blind, placebo-controlled, randomized clinical trial, 16 patients with intractable OCD were randomized to active (n = 8) or sham (n = 8) GVC. Blinding was maintained for 12 months. After unblinding, sham-group patients were offered active GVC. INTERVENTIONS Patients randomized to active GVC had 2 distinct isocenters on each side irradiated at the ventral border of the anterior limb of the internal capsule. The patients randomized to sham GVC received simulated radiosurgery using the same equipment. MAIN OUTCOMES AND MEASURES Scores on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and the Clinical Global Impression-Improvement (CGI-I) Scale. Response was defined as a 35% or greater reduction in Y-BOCS severity and ""improved"" or ""much improved"" CGI-I ratings. RESULTS Three of 8 patients randomized to active treatment responded at 12 months, while none of the 8 sham-GVC patients responded (absolute risk reduction, 0.375; 95% CI, 0.04-0.71). At 12 months, OCD symptom improvement was significantly higher in the active-GVC group than in the sham group (Y-BOCS, P = .046; Dimensional Y-BOCS, P = .01). At 54 months, 2 additional patients in the active group had become responders. Of the 4 sham-GVC patients who later received active GVC, 2 responded by post-GVC month 12. The most serious adverse event was an asymptomatic radiation-induced cyst in 1 patient. CONCLUSIONS AND RELEVANCE Gamma ventral capsulotomy benefitted patients with otherwise intractable OCD and thus appears to be an alternative to deep-brain stimulation in selected cases. Given the risks inherent in any psychiatric neurosurgery, such procedures should be conducted at specialized centers.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MDR
Departamento de Radiologia - FM/MDR

Artigos e Materiais de Revistas Científicas - FM/MPS
Departamento de Psiquiatria - FM/MPS

Artigos e Materiais de Revistas Científicas - HC/InRad
Instituto de Radiologia - HC/InRad

Artigos e Materiais de Revistas Científicas - HC/IPq
Instituto de Psiquiatria - HC/IPq

Artigos e Materiais de Revistas Científicas - LIM/21
LIM/21 - Laboratório de Neuroimagem em Psiquiatria

Artigos e Materiais de Revistas Científicas - LIM/44
LIM/44 - Laboratório de Ressonância Magnética em Neurorradiologia


Files in This Item:
File Description SizeFormat 
art_LOPES_Gamma_Ventral_Capsulotomy_for_ObsessiveCompulsive_Disorder_A_Randomized_2014.PDF
  Restricted Access
publishedVersion (English)341.88 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.